Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 04, 2013 16:01 ET | Source: QLT Inc.

QLT Completes Sale of Punctal Plug Technology to Mati Therapeutics

VANCOUVER, British Columbia, April 4, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced today that it has completed the sale of the Company's punctal plug...
February 21, 2013 16:05 ET | Source: QLT Inc.

QLT Announces Fourth Quarter and Year End 2012 Results

VANCOUVER, British Columbia, Feb. 21, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization...
January 28, 2013 08:00 ET | Source: QLT Inc.

QLT Board Issues Letter to Shareholders Announcing Corporate Progress and 2013 Objectives

VANCOUVER, British Columbia, Jan. 28, 2013 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today issued the following letter to its shareholders outlining the Company's recent progress and its...
December 24, 2012 08:00 ET | Source: QLT Inc.

QLT Announces Exclusive Option Agreement for Potential Sale of Punctal Plug Delivery System

VANCOUVER, British Columbia, Dec. 24, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced today that the Company has entered into an exclusive option agreement...
December 06, 2012 08:00 ET | Source: QLT Inc.

QLT Announces Reduction in Force

VANCOUVER, British Columbia, Dec. 6, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) today announced a 42% reduction of its workforce to better align its resources with the Company's...
November 07, 2012 07:30 ET | Source: QLT Inc.

QLT Announces Third Quarter 2012 Results

VANCOUVER, British Columbia, Nov. 7, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of...
October 24, 2012 17:01 ET | Source: QLT Inc.

QLT Shows Positive Efficacy Trends From Data in Plug Combinations in Phase II Studies for Glaucoma Using Latanoprost Punctal Plug Delivery System

VANCOUVER, British Columbia, Oct. 24, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) announced that results from two Phase II clinical studies, PPL GLAU 12 and PPL GLAU 13, demonstrate...
September 27, 2012 08:30 ET | Source: QLT Inc.

QLT Announces Share Repurchase Program

VANCOUVER, British Columbia, Sept. 27, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") announced today that its board of directors has approved a share repurchase...
September 24, 2012 07:30 ET | Source: QLT Inc.

QLT Announces Sale of Visudyne(R) to Valeant Pharmaceuticals

VANCOUVER, British Columbia, Sept. 24, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) announced today that it has completed the sale of the Company's Visudyne® business to Valeant...
August 02, 2012 08:00 ET | Source: QLT Inc.

QLT Announces Second Quarter 2012 Results

VANCOUVER, British Columbia, Aug. 2, 2012 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq:QLTI) (TSX:QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of...